Skip to main content

Table 4 Unadjusted and adjusted PR for association between satisfaction with care and viral suppression at first annual visit after enrollment

From: Perceived satisfaction with HIV care and its association with adherence to antiretroviral therapy and viral suppression in the African Cohort Study

 

PR (95% CI)

aPR (95% CI)

Satisfaction with care

  

 Needs improvement

Ref

–

 Doesn’t need improvement

1.04 (0.98-1.11)

1.03 (0.97–1.09)

Study site

  

 Kayunga, Uganda

Ref

–

 South Rift Valley, Kenya

1.05 (1.00–1.10)

1.04 (0.99–1.09)

 Kisumu West, Kenya

1.07 (1.01-1.12)

1.06 (1.01-1.12)

 Mbeya, Tanzania

0.96 (0.91–1.02)

0.96 (0.91–1.02)

 Abuja & Lagos Nigeria

1.02 (0.95–1.09)

1.01 (0.95–1.09)

Age (years)

  

 18–29

Ref

-

 30–39

1.04 (0.98–1.10)

1.03 (0.97–1.10)

 40–49

1.11 (1.05–1.17)

1.10 (1.04–1.17)

 50+

1.10 (1.03–1.17)

1.09 (1.03–1.16)

Sex

  

 Male

Ref

 

 Female

0.98 (0.95–1.01)

 

Currently employed

  

 No

Ref

 

 Yes

1.00 (0.97–1.03)

 

Education

  

 Primary or less

Ref

 

 Secondary or above

1.00 (0.96–1.03)

 

Enough food to eat in past 12 months

  

 No

Ref

 

 Yes

0.99 (0.95–1.02)

 

Distance from facility (km)

1.00 (1.00–1.00)

 

Time since HIV diagnosis

  

 < 1 year

Ref

 

 1 to 4 years

1.16 (0.92–1.47)

 

 5 to 9 years

1.24 (0.98–1.57)

 

 10 or more years

1.23 (0.97–1.56)

 

Duration on ART

  

 ART naïve

Ref

 

 < 6 months

4.40 (3.13–6.18)

 

 6 months to < 2 years

4.28 (3.06–5.99)

 

 2 years to < 4 years

4.36 (3.11–6.10)

 

 ≥ 4 years

4.27 (3.05–5.98)

 
  1. Robust Poisson regression was used to estimate prevalence ratios and 95% confidence intervals (CIs) for associations between satisfaction with care and viral suppression (viral load <1000 copies/mL). Bold indicates significance at p < 0.05